AzTrials
AzTrials

Exclusive BreastfeedingPROMILACTNCT07593716

Effect of a Self-Efficacy-Based Educational Intervention on Breastfeending in Primigravid Women: A Randomized Controlled Trial

A study testing Breastfeeding Self-Efficacy Educational Program in people with Exclusive Breastfeeding and Breastfeeding Self-Efficacy, run by Instituto Mexicano del Seguro Social at 1 site in Mexico.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled trial aims to evaluate the effect of a self-efficacy-based educational intervention on exclusive breastfeeding among primigravid women attending a primary care center in Mexico. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
What is being tested?
Breastfeeding Self-Efficacy Educational Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
160 participants
Where
1 siteMexico
Study dates
May 2026to Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Pregnant women aged 18 years or older
  • Primigravidae in the third trimester of pregnancy
  • Receiving prenatal care at UMF No. 9, IMSS
  • Ability to attend the educational sessions
  • Willingness to participate and sign informed consent

Who cannot join

  • High-risk pregnancy
  • Medical conditions contraindicating breastfeeding
  • Cognitive impairment or communication difficulties preventing participation
  • Previous participation in breastfeeding educational programs
  • Failure to complete follow-up evaluations

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Guadalupe Aguilar Hernández, MD contact

+527442298212

guadalupe.aguilarhe@imss.gob.mx

Mexico1 site
  • Unidad de Medicina Familiar No. 9

    Acapulco de Juárez, Guerrero, 39300

    Guadalupe Aguilar Hernández, MD, +52 7442298212, guadalupe.aguilarhe@imss.gob.mx

    Guadalupe Aguilar Hernández, MD

Other trials in Mexico

About this study

Official title: Effect of a Self-Efficacy-Based Educational Intervention on Exclusive Breastfeeding in Primigravid Women Attending a Primary Care Center: A Randomized Controlled Trial

This randomized controlled trial aims to evaluate the effect of a self-efficacy-based educational intervention on exclusive breastfeeding among primigravid women attending a primary care center in Mexico. Participants in the intervention group will receive four weekly educational sessions focused on breastfeeding knowledge, self-efficacy, problem-solving skills, and emotional support during the third trimester of pregnancy. The control group will receive standard prenatal care. Breastfeeding self-efficacy and exclusive breastfeeding rates will be evaluated during postpartum follow-up at 1 and 3 months after delivery.

Read the detailed description

Exclusive breastfeeding is recognized as one of the most effective interventions for improving maternal and infant health outcomes. However, breastfeeding rates remain below international recommendations in many settings, particularly among first-time mothers who may experience uncertainty, lack of confidence, and insufficient support during the prenatal and postpartum periods.

Self-efficacy theory suggests that maternal confidence plays a critical role in breastfeeding initiation and maintenance. Educational interventions based on self-efficacy principles may improve breastfeeding behaviors and increase exclusive breastfeeding duration.

This study is a randomized controlled trial conducted in a primary care setting of the Mexican Social Security Institute (IMSS) in Acapulco, Guerrero, Mexico. The study will include primigravid women in the third trimester of pregnancy receiving prenatal care at Unidad de Medicina Familiar No. 9.

Participants assigned to the intervention group will receive a structured educational intervention consisting of four weekly sessions lasting approximately 90 minutes each. The sessions will address breastfeeding physiology, breastfeeding techniques, common breastfeeding difficulties, emotional support, and strategies to improve maternal self-efficacy. The control group will continue receiving standard prenatal care routinely provided by the institution.

The primary outcomes will include breastfeeding self-efficacy and exclusive breastfeeding rates during postpartum follow-up. Secondary outcomes may include breastfeeding knowledge and breastfeeding continuation at different postpartum time points.

Breastfeeding self-efficacy will be evaluated using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF). Follow-up evaluations will be performed at 1 and 3 months postpartum.

Being tested
Breastfeeding Self-Efficacy Educational Program
Keywords
Breastfeeding, Primigravid Women, Educational Intervention, Randomized Controlled Trial, BSES-SF, Primary Care, Mexico
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breastfeeding Self-Efficacy Educational ProgramBehavioural

    Participants will receive four weekly educational sessions during the third trimester of pregnancy based on breastfeeding self-efficacy theory. Sessions will include breastfeeding education, practical techniques, confidence building, problem-solving strategies, and support to improve exclusive breastfeeding practices postpartum.

Study groups in NCT07593716
Study groupRoleWhat they receive
Educational Intervention GroupExperimentalParticipants will receive a breastfeeding educational intervention based on self-efficacy theory during the third trimester of pregnancy. The intervention includes four weekly sessions focused on breastfeeding knowledge, techniques, confidence building, and problem-solving strategies.
Receives: Behavioral: Breastfeeding Self-Efficacy Educational Program
Control GroupNo interventionParticipants will receive standard prenatal care routinely provided at the family medicine unit without the additional breastfeeding educational intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exclusive Breastfeeding Rate at 3 Months Postpartum

    Proportion of mothers who maintain exclusive breastfeeding at 3 months postpartum after receiving an educational intervention based on breastfeeding self-efficacy.

    Measured: 3 months postpartum

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2026
  2. Study startMay 2026 (estimated)
  3. Primary completionJun 2027 (estimated)
  4. Study completionAug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to either an educational intervention group based on breastfeeding self-efficacy or a control group receiving standard prenatal care. Both groups will be followed during pregnancy and evaluated at 1 and 3 months postpartum.
Masking
None (open label)
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07593716
Sponsor's protocol ID
IMSS-UMF-BSES-2026
Other IDs
R-2026-1101-006
Acronym
PROMILACT
Status last verified
May 2026
First submitted
12 May 2026
Last updated
18 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be publicly available due to institutional privacy and confidentiality policies.

Questions about this trial

What is this clinical trial studying?

A study testing Breastfeeding Self-Efficacy Educational Program in people with Exclusive Breastfeeding and Breastfeeding Self-Efficacy, run by Instituto Mexicano del Seguro Social at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Guadalupe Aguilar Hernández, MD (+527442298212, guadalupe.aguilarhe@imss.gob.mx), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exclusive Breastfeeding Rate at 3 Months Postpartum (time frame: 3 months postpartum). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in